Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3-hydroxyacyl-CoA dehydratase 1 | 0.539 | 0.846 | 1.3E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.150 | None | 1.000 | 5 | 0 | 1996 | 2017 | ||||||||
|
acyl-CoA synthetase medium chain family member 3 | 0.623 | 0.615 | 1.4E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
arginase 1 | 0.476 | 0.846 | 3.6E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
arthrogryposis multiplex congenita, neurogenic | 0.682 | 0.615 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
phenotype | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily G member 1 | 0.560 | 0.692 | 0.11 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.130 | None | 1.000 | 3 | 0 | 1990 | 2017 | ||||||||
|
beta-1,3-glucuronyltransferase 1 | 0.494 | 0.769 | 0.14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
bromodomain containing 4 | 0.446 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1991 | 2018 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 2011 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.030 | None | 1.000 | 2 | 0 | 1991 | 2011 |